EUVIMEDEUVIMED entdecken
Crossref

Mathematical model of tumor immune microenvironment with application to the combined therapy targeting the PD-1/PD-L1 pathway and IL-10 cytokine antibody

Zixin Zhang, Xiyin Liang, Jianyong Qin, Jinzhi Lei

Theory in Biosciences · 2025

DOI: 10.1007/s12064-024-00428-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theory in Biosciences, 2025. Verfasst von Zixin Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Mathematical Sciences, Center for Applied Mathematics, Tiangong University, Tianjin, 300387, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Interleukin-10, Neoplasms, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor microenvironment constitutes a complex system shaped by the intricate interactions among tumor cells, immune cells, and cytokines. Within this environment, the interplay between immune cells and cytokines is crucial in influencing tumor growth and progression. Despite advancements in clinical tumor immunotherapy, there remains a gap in comprehensive simulations of tumor immune responses, particularly regarding cytokine-driven processes. This study aims to address this gap by investigating the regulatory interactions among tumor cells, immune cells, and cytokines to simulate the complexities of tumor immunotherapy. We develop a comprehensive modeling and computational framework incorporating PD-1 inhibitors and interleukin-10 (IL-10) antibodies. Through detailed mathematical analysis, we elucidate the impact of changes in the immune microenvironment on tumor cells number. Our findings highlight the significant therapeutic effect of anti-PD-1 and IL-10 inhibitors, with increased drug dosage correlating with a reduction in tumor burden. Furthermore, combination therapy demonstrates a marked extension of survival with reduced dosages compared to monotherapy. Based on model simulations, we proposed prognostic predictions by assessing the microenvironmental status before treatment. The findings indicate a promising method for enhancing treatment effectiveness and offering potential advantages to patients receiving tumor immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentInterleukin-10NeoplasmsProgrammed Cell Death 1 ReceptorB7-H1 AntigenHumansImmunotherapyComputer SimulationImmune Checkpoint InhibitorsModels, TheoreticalSignal TransductionModels, Biological

Stichwörter der Autor:innen

CytokinesImmunotherapyMathematical modelPD-1/PD-L1Tumor immunity

Substanzen

Interleukin-10Programmed Cell Death 1 ReceptorB7-H1 AntigenCD274 protein, humanPDCD1 protein, humanIL10 protein, humanImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • School of Mathematical Sciences, Center for Applied Mathematics, Tiangong University, Tianjin, 300387, China.
  • Liwan Central Hospital of Guangzhou, Liwan Road 35, Guangzhou, 510170, China.
  • School of Mathematical Sciences, Center for Applied Mathematics, Tiangong University, Tianjin, 300387, China. jzlei@tiangong.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Z., Liang, X., Qin, J., & Lei, J. (2025). Mathematical model of tumor immune microenvironment with application to the combined therapy targeting the PD-1/PD-L1 pathway and IL-10 cytokine antibody. Theory in Biosciences. https://doi.org/10.1007/s12064-024-00428-1

Vancouver

Zhang Z, Liang X, Qin J, Lei J. Mathematical model of tumor immune microenvironment with application to the combined therapy targeting the PD-1/PD-L1 pathway and IL-10 cytokine antibody. Theory in Biosciences. 2025. doi:10.1007/s12064-024-00428-1

BibTeX
@article{Zhang2025,
  author = {Zhang, Zixin and Liang, Xiyin and Qin, Jianyong and Lei, Jinzhi},
  title = {Mathematical model of tumor immune microenvironment with application to the combined therapy targeting the PD-1/PD-L1 pathway and IL-10 cytokine antibody},
  journal = {Theory in Biosciences},
  year = {2025},
  doi = {10.1007/s12064-024-00428-1}
}
Kostenlos starten →